Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,982 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Carcinosarcoma of the ovary].
Muller M, Dupre PF, Lucas B, Simon H, Malhaire JP, Guillemet C, Dessogne P, Pradier O. Muller M, et al. Among authors: simon h. J Gynecol Obstet Biol Reprod (Paris). 2007 Jun;36(4):399-402. doi: 10.1016/j.jgyn.2007.03.001. Epub 2007 Apr 3. J Gynecol Obstet Biol Reprod (Paris). 2007. PMID: 17408876 Free article. French.
The self-reported perceptions of the repercussions of the disease and its treatments on daily life for young women with breast cancer and their partners.
Congard A, Christophe V, Duprez C, Baudry AS, Antoine P, Lesur A, Loustalot C, Guillemet C, Leclercq M, Segura C, Carlier D, Lefeuvre-Plesse C, Simon H, Frenel JS, Vanlemmens L. Congard A, et al. Among authors: simon h. J Psychosoc Oncol. 2019 Jan-Feb;37(1):50-68. doi: 10.1080/07347332.2018.1479326. Epub 2018 Oct 8. J Psychosoc Oncol. 2019. PMID: 30295567
A Pragmatic Study Evaluating NEPA Versus Aprepitant for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy.
Zelek L, Debourdeau P, Bourgeois H, Wagner JP, Brocard F, Lefeuvre-Plesse C, Chauffert B, Leheurteur M, Bachet JB, Simon H, Mayeur D, Scotté F. Zelek L, et al. Among authors: simon h. Oncologist. 2021 Oct;26(10):e1870-e1879. doi: 10.1002/onco.13888. Epub 2021 Jul 22. Oncologist. 2021. PMID: 34216177 Free PMC article. Clinical Trial.
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer.
Modi S, Jacot W, Yamashita T, Sohn J, Vidal M, Tokunaga E, Tsurutani J, Ueno NT, Prat A, Chae YS, Lee KS, Niikura N, Park YH, Xu B, Wang X, Gil-Gil M, Li W, Pierga JY, Im SA, Moore HCF, Rugo HS, Yerushalmi R, Zagouri F, Gombos A, Kim SB, Liu Q, Luo T, Saura C, Schmid P, Sun T, Gambhire D, Yung L, Wang Y, Singh J, Vitazka P, Meinhardt G, Harbeck N, Cameron DA; DESTINY-Breast04 Trial Investigators. Modi S, et al. N Engl J Med. 2022 Jul 7;387(1):9-20. doi: 10.1056/NEJMoa2203690. Epub 2022 Jun 5. N Engl J Med. 2022. PMID: 35665782 Free PMC article. Clinical Trial.
[Pyoderma gangrenosum and breast cancer: a new case].
Labat JP, Simon H, Metges JP, Lucas B, Malhaire JP. Labat JP, et al. Among authors: simon h. Ann Med Interne (Paris). 2000 Jun;151(4):314-5. Ann Med Interne (Paris). 2000. PMID: 10922963 French.
Epirubicin-vinorelbine vs FEC100 for node-positive, early breast cancer: French Adjuvant Study Group 09 trial.
Kerbrat P, Roché H, Bonneterre J, Veyret C, Lortholary A, Monnier A, Fumoleau P, Fargeot P, Namer M, Chollet P, Goudier MJ, Audhuy B, Simon H, Montcuquet P, Eymard JC, Walter S, Clavère P, Guastalla JP; French adjuvant Study Group. Kerbrat P, et al. Among authors: simon h. Br J Cancer. 2007 Jun 4;96(11):1633-8. doi: 10.1038/sj.bjc.6603773. Epub 2007 May 15. Br J Cancer. 2007. PMID: 17505516 Free PMC article. Clinical Trial.
Real-World Data on Olaparib in Relapsed BRCA-mutated Ovarian Cancer: A Multicenter GINECO RETROLA Cohort Study.
Bourien H, Lefevre LB, Mouret-Reynier MA, Asselain B, Lucas B, Gavoille C, Cornila C, Gavoille L, Colomba E, Patsouris A, Fabbro M, Chakiba C, Toussaint P, Simon H, Berton D, Garbay D, Tixidre CG, Coeffic D, Morvan A, Collard O, DE LA Motte Rouge T. Bourien H, et al. Among authors: simon h. Anticancer Res. 2023 Feb;43(2):653-662. doi: 10.21873/anticanres.16202. Anticancer Res. 2023. PMID: 36697069
1,982 results